Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05026320Phase 2Completed
A Phase 2 trial of naproxen in soft tissue injury, sponsored by Bayer. Started Aug 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05026320.